AMH Predicts Postchemotherapy Menopause in Premenopausal Breast Cancer Patients
NCT06313476 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 153
Last updated 2024-03-15
Summary
To determine the accuracy of AMH postchemotherapy in predicting permanent menopause after chemotherapy in breast cancer patients who did not use OFS before menopause
Conditions
Sponsors & Collaborators
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
lead OTHER
Eligibility
- Min Age
- 40 Years
- Max Age
- 59 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-03-15
- Primary Completion
- 2026-04-30
- Completion
- 2026-04-30
More Related Trials
-
A Prospective Observational Study About Adjuvant or Neoadjuvant Chemotherapy Related Adverse Effects in Premenopausal Breast Cancer Patients
NCT03543059 ·Status: UNKNOWN
-
Maintenance Hormone Therapy for Postmenopausal HR Positive Advanced Breast Cancer
NCT02000193 ·Status: UNKNOWN ·Phase: PHASE2
-
A Real-world Study on the Compliance of OFS-assisted Endocrine Therapy for Hormone Receptor-positive(HR+) Premenopausal Breast Cancer
NCT07180914 ·Status: NOT_YET_RECRUITING
-
Anti-Mullerian Hormone (AMH) as Marker of Ovarian Reserve
NCT02113553 ·Status: TERMINATED ·Phase: PHASE2
-
Comparative Evaluation of Efficacy and Safety of Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian Function Suppression in Hormone Receptor-Positive Early Breast Cancer Among Non-Low-Risk Premenopausal Women: A Real-World Study
NCT05801705 ·Status: UNKNOWN
-
Study of Preservation of Ovarian Reserve During Chemotherapy for Young Breast Cancer Patients
NCT02430103 ·Status: ACTIVE_NOT_RECRUITING
-
Prognostic Evaluation of Changing Endocrine Therapy in Women With Breast Cancer
NCT02097459 ·Status: UNKNOWN ·Phase: PHASE3
-
Assessing Gonadotropin-Releasing Hormone Agonists Benefit in Preserving the Ovarian Function in Premenopausal Breast Cancer Patients During Chemotherapy
NCT07127315 ·Status: COMPLETED
-
Adjuvant Ovarian Suppression Plus Aromatase Inhibitor or Tamoxifen in Young Women
NCT02914158 ·Status: RECRUITING ·Phase: PHASE3
-
Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors
NCT01758146 ·Status: UNKNOWN ·Phase: PHASE3
-
Clinical Study of Adjuvant Therapy on Post-menopausal Women With Breast Cancer Under the Guidance of the Results of Preoperative Endocrinotherapy
NCT01613560 ·Status: UNKNOWN ·Phase: PHASE2
-
Evaluation of Individual Sensitivity to the Gonadotoxicity of Chemotherapy in Young Patients With Breast Cancer
NCT03731845 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Adjuvant Toremifene With or Without Goserrelin in Premenopausal Women With Stage I-IIIA, Hormonal Receptor Positive Breast Cancer Accompanied With or Without Chemotherapy Induced Amenorrhoea
NCT02132390 ·Status: UNKNOWN ·Phase: PHASE3
-
Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive Patients
NCT00309478 ·Status: COMPLETED ·Phase: PHASE3
-
A Prospective Observational Study About Adjuvant or Neoadjuvant Chemotherapy Related Adverse Effects in Postmenopausal Breast Cancer Patients
NCT03543072 ·Status: UNKNOWN
-
Safety of OFS Combined With AI Endocrine Therapy in Chinese Premenopausal Breast Cancer Patients
NCT02440230 ·Status: COMPLETED ·Phase: PHASE2
-
Predictors of Ovarian Insufficiency in Young Breast Cancer Patients
NCT01197456 ·Status: COMPLETED
-
Ovarian Reserve in Premenopausal Breast Cancer
NCT01726322 ·Status: TERMINATED
-
Efficacy of High Dose Tamoxifen to Advanced Hormone Receptor-High Expressed Breast Cancer
NCT03045653 ·Status: COMPLETED ·Phase: PHASE2
-
Goserelin in Preventing Early Menopause in Premenopausal Women Undergoing Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer
NCT00427245 ·Status: COMPLETED ·Phase: PHASE3
-
Investigating the Impact of Tamoxifen Therapy on Ovarian Aging
NCT01384526 ·Status: COMPLETED
-
Phase III, Randomized, Double Blind Trial Low Dose Tamoxifen Versus Placebo in Hormone Replacement Therapy (HRT) Users
NCT01579734 ·Status: UNKNOWN ·Phase: PHASE3
-
Primary Progesterone Therapy for Operable Breast Cancer
NCT00123669 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Prospective Observational Study of Adjuvant Hormone Treatment in Estrogen-receptor Positive Premenopausal Early Breast Cancer Patients
NCT05730647 ·Status: ACTIVE_NOT_RECRUITING
-
A Prospective,Open-label Study of Anastrozole in Post-menopausal Women With Hormone Sensitive Advanced Breast Cancer
NCT00544986 ·Status: COMPLETED ·Phase: PHASE4